IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
Guo, Jian-hai; Zhu, Xu; Li, Xiao-ting; Yang, Ren-jie
关键词Hepatocellular Carcinoma Vascular Endothelial Growth Factor Tace Elisa
刊名CHINESE JOURNAL OF CANCER RESEARCH
2012-03-01
DOI10.1007/s11670-012-0036-8
24期:1页:36-43
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
资助者National Science &amp ; Technology Major Project of China ; National Science &amp ; Technology Major Project of China
研究领域[WOS]Oncology
关键词[WOS]LIVER-TRANSPLANTATION ; FACTOR EXPRESSION ; SURVIVAL ANALYSIS ; THERMAL ABLATION ; ANGIOGENESIS ; CANCER ; VEGF ; NEOVASCULARIZATION ; INVASIVENESS ; RECURRENCE
英文摘要

To investigate the expression level of serum vascular endothelial growth factor (VEGF) in patients with unresectable hepatocellular carcinoma (HCC) and its relationship with the clinicopathological characteristics, and to assess the impact of serum VEGF as a predictive factor for HCC prognosis during transarterial chemoembolization (TACE) treatments.

Serum VEGF levels were measured using enzyme-linked immunosorbent assay (ELISA) in 60 random patients who underwent TACE or transarterial infusion (TAI) for unresectable HCC between May and September 2008 and 12 healthy volunteers were also involved in this study to serve as control. All patients′ clinicopathological features were retrospectively analyzed. Serum VEGF levels were correlated with clinicopathological features of the HCC patients. The patients′ survival rates were analyzed with Kaplan-Meier survival curves and compared by the log-rank test. The prognostic significance of serum VEGF levels and factors related to survival rate were evaluated by univariate and multivariate analysis.

The median serum VEGF level in the HCC patients was 285 pg/ml (range 14-1,207 pg/ml), significantly higher than that of healthy controls (P=0.021). The serum VEGF levels were significantly correlated with platelet counts (r=0.396, P=0.002) but not other clinicopathological features. Patients with serum VEGF level > 285 pg/ml had worse overall survival compared with those with serum VEGF level < 285 pg/ml (P=0.002). By multivariate analysis, the serum VEGF level was a significant prognostic factor.

High serum VEGF levels may predict poor prognosis of HCC after TACE. This study highlights the importance of tumor biomarker as a prognostic predictor in TACE therapy for HCC, which has an intrinsic problem of unavailability of histopathological prognostic features.

语种英语
所属项目编号2008ZX10002-026
资助者National Science &amp ; Technology Major Project of China ; National Science &amp ; Technology Major Project of China
WOS记录号WOS:000300313500006
引用统计
被引频次:11[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/50671
专题北京大学临床肿瘤学院
作者单位Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Intervent Therapy, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
推荐引用方式
GB/T 7714
Guo, Jian-hai,Zhu, Xu,Li, Xiao-ting,et al. Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization[J]. CHINESE JOURNAL OF CANCER RESEARCH,2012,24(1):36-43.
APA Guo, Jian-hai,Zhu, Xu,Li, Xiao-ting,&Yang, Ren-jie.(2012).Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.CHINESE JOURNAL OF CANCER RESEARCH,24(1),36-43.
MLA Guo, Jian-hai,et al."Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization".CHINESE JOURNAL OF CANCER RESEARCH 24.1(2012):36-43.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Guo, Jian-hai]的文章
[Zhu, Xu]的文章
[Li, Xiao-ting]的文章
百度学术
百度学术中相似的文章
[Guo, Jian-hai]的文章
[Zhu, Xu]的文章
[Li, Xiao-ting]的文章
必应学术
必应学术中相似的文章
[Guo, Jian-hai]的文章
[Zhu, Xu]的文章
[Li, Xiao-ting]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。